CHLORZOXAZONE Drug Patent Profile
✉ Email this page to a colleague
When do Chlorzoxazone patents expire, and when can generic versions of Chlorzoxazone launch?
Chlorzoxazone is a drug marketed by Acme Labs, Actavis Elizabeth, Aurobindo Pharma Ltd, Barr, Belcher, Chartwell Rx, Corepharma, Dr Reddys Labs Sa, Endo Operations, Glenmark Pharms Ltd, Mikart, Novitium Pharma, Ohm Labs, Pioneer Pharms, Rising, Senores Pharms, Strides Pharma, Sun Pharm Industries, Teva Pharms Usa Inc, Upsher Smith Labs, and Watson Labs. and is included in thirty-five NDAs.
The generic ingredient in CHLORZOXAZONE is chlorzoxazone. There are sixteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Chlorzoxazone
A generic version of CHLORZOXAZONE was approved as chlorzoxazone by AUROBINDO PHARMA LTD on May 4th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHLORZOXAZONE?
- What are the global sales for CHLORZOXAZONE?
- What is Average Wholesale Price for CHLORZOXAZONE?
Summary for CHLORZOXAZONE
| US Patents: | 0 |
| Applicants: | 21 |
| NDAs: | 35 |
| Finished Product Suppliers / Packagers: | 25 |
| Raw Ingredient (Bulk) Api Vendors: | 137 |
| Clinical Trials: | 10 |
| Patent Applications: | 3,708 |
| Drug Prices: | Drug price information for CHLORZOXAZONE |
| DailyMed Link: | CHLORZOXAZONE at DailyMed |
Recent Clinical Trials for CHLORZOXAZONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Texas Southwestern Medical Center | Phase 1 |
| Tufts University | Phase 1 |
| Marian Hajduch, M.D., Ph.D. | Phase 2 |
Pharmacology for CHLORZOXAZONE
| Drug Class | Muscle Relaxant |
| Physiological Effect | Centrally-mediated Muscle Relaxation |
Medical Subject Heading (MeSH) Categories for CHLORZOXAZONE
Anatomical Therapeutic Chemical (ATC) Classes for CHLORZOXAZONE
US Patents and Regulatory Information for CHLORZOXAZONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms Usa Inc | CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 212898-001 | Jun 17, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rising | CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 089852-001 | May 4, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 081040-001 | Aug 22, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 086901-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 089859-001 | May 4, 1988 | AA | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
